(Q33539499)

27 July 2017

1 reference

title

Muscarinic antagonists in development for disorders of smooth muscle function (English)

1 reference

27 July 2017

Wallis RM

1

1 reference

27 July 2017

Napier CM

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

64

1 reference

27 July 2017

issue

6-7

1 reference

27 July 2017

page(s)

395-401

1 reference

Muscarinic receptors--characterization, coupling and function

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Discovery & development of selective M3 antagonists for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Tolterodine--a new bladder-selective antimuscarinic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900585-2

10.1016/S0024-3205(98)00585-2

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference